SLITRK1

There are 2 papers on SLITRK1 in aging research: 1 trial and 1 observational study in people. The newest story, Nov 16, 2026: “Canagliflozin linked to urine protein shifts in kidney disease”.

Gene

2 papers study it

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 2 papers on SLITRK1

  • Human trial1
  • Humans1

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Diabetes, Obesity & Metabolism

Canagliflozin linked to urine protein shifts in kidney disease

After one year, 124 urinary proteins changed with canagliflozin compared with placebo in people with type 2 diabetes and chronic kidney disease.After one year, 124 urinary proteins changed with canagliflozin compared with placebo in people with type 2 diabetes and chronic kidney disease.

Case-control · 337 peopleCanagliflozin